Black Rock Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,649,838 shares of ARCT stock, worth $48.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,649,838
Previous 2,743,002
3.4%
Holding current value
$48.6 Million
Previous $92.6 Million
30.34%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ARCT
# of Institutions
189Shares Held
26.8MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$86.1 Million0.28% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.28MShares$41.8 Million0.04% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$38.6 Million0.46% of portfolio
-
Nikko Asset Management Americas, Inc.1.56MShares$28.7 Million0.44% of portfolio
-
State Street Corp Boston, MA1.52MShares$28 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $488M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...